Brattea

Xuhui, China Founded: 2013 • Age: 13 yrs
Developer of a medical device for the treatment of hypertension
Request Access

About Brattea

Brattea is a company based in Xuhui (China) founded in 2013 by Hongguang Cao.. Brattea has raised $15.2 million across 3 funding rounds from investors including Zhongping Capital, Shanghai Healthcare Capital and Shenzhen Dingxin Capital Management. Brattea operates in a competitive market with competitors including ReCor Medical, Ablative Solutions, Autonomix, Kalos Medical and Maya Medical, among others.

  • Headquarter Xuhui, China
  • Founders Hongguang Cao
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15.2 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Brattea

Brattea has successfully raised a total of $15.2M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (05 Apr 2021)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2024 Amount Series D - Brattea Valuation Zhongping Capital
Dec, 2022 Amount Series C - Brattea Valuation Fosunhealth
Apr, 2021 Amount Series B - Brattea Valuation Kuanping Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Brattea

Brattea has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Zhongping Capital, Shanghai Healthcare Capital and Shenzhen Dingxin Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Venture capital firm investing in series A startups
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Brattea

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Brattea

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Brattea Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Brattea

Brattea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ReCor Medical, Ablative Solutions, Autonomix, Kalos Medical and Maya Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Ultrasound-based renal denervation is applied for hypertension treatment.
domain founded_year HQ Location
A catheter-based renal denervation system for hypertension treatment is developed.
domain founded_year HQ Location
Minimally invasive neural monitoring and treatment devices are developed.
domain founded_year HQ Location
Developer of medical devices for the treatment of hypertension & other chronic diseases
domain founded_year HQ Location
Catheter based ablative technology for renal denervation to treat hypertension
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Brattea

When was Brattea founded?

Brattea was founded in 2013 and raised its 1st funding round 8 years after it was founded.

Where is Brattea located?

Brattea is headquartered in Xuhui, China. It is registered at Xuhui, Shanghai, China.

Is Brattea a funded company?

Brattea is a funded company, having raised a total of $15.2M across 3 funding rounds to date. The company's 1st funding round was a Series B of $15.2M, raised on Apr 05, 2021.

What does Brattea do?

Developer of a medical device for the treatment of hypertension. The product is a Renal artery radiofrequency ablation instrument, a minimally invasive way to deliver the catheter into the renal artery, that performs radiofrequency ablation of the renal artery sympathetic nerve and blocks the sympathetic nerve to treat hypertension and chronic kidney disease hypertension. This device has a mesh basket structure and 6 electrodes. The company also works in the field of tumor analgesia, diabetes, vasculitis, and heart disease.

Who are the top competitors of Brattea?

Brattea's top competitors include ReCor Medical, Autonomix and Ablative Solutions.

Who are Brattea's investors?

Brattea has 9 investors. Key investors include Zhongping Capital, Shanghai Healthcare Capital, Shenzhen Dingxin Capital Management, Fosunhealth, and NNFE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available